Direktorat Registrasi ObatValid

LAPISIV

Claim this product
BPOM Number
DKL9113302937A1
Approved
21 November 2024
Expiry
1 July 2025
Form
SIRUP; 100 MG /7.5 MG /12.5 MG /75 MG /6 MG /50 MG

About This Registration

LAPISIV is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKL9113302937A1. Its current registration status is Valid, with the licence valid until 1 July 2025. The product is registered to LAPI LABORATORIES - INDONESIA. BPOM first approved this registration in March 2022. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 1 BOTOL @ 100 ML
Department
Direktorat Registrasi Obat
Data Last Updated
13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Ingredients (1)

AMMONIUM CHLORIDE. DEXTROMETHORPHAN HYDROBROMIDE. DIPHENHYDRAMINE HYDROCHLORIDE. GUAIFENESIN. PHENYLPROPANOLAMINE HYDROCHLORIDE. SODIUM CITRATE

Market Intelligence

Owner Portfolio
LAPI LABORATORIES - INDONESIA holds 249 BPOM registrations
Manufacturer Scale
LAPI LABORATORIES - INDONESIA produces 249 registered products
Registration Age
Registered for 4 years, 6 months
Expiry Status
Expired 451 days ago

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1